These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19487289)

  • 21. Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library.
    Brožič P; Turk S; Adeniji AO; Konc J; Janežič D; Penning TM; Lanišnik Rižner T; Gobec S
    J Med Chem; 2012 Sep; 55(17):7417-24. PubMed ID: 22881866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives.
    Sinreih M; Jójárt R; Kele Z; Büdefeld T; Paragi G; Mernyák E; Rižner TL
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1500-1508. PubMed ID: 34227437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of heat shock protein 72 in C6 glioma cells by methyl jasmonate through ROS-dependent heat shock factor 1 activation.
    Oh SY; Kim JH; Park MJ; Kim SM; Yoon CS; Joo YM; Park JS; Han SI; Park HG; Kang HS
    Int J Mol Med; 2005 Nov; 16(5):833-9. PubMed ID: 16211252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methyl jasmonate induces production of reactive oxygen species and alterations in mitochondrial dynamics that precede photosynthetic dysfunction and subsequent cell death.
    Zhang L; Xing D
    Plant Cell Physiol; 2008 Jul; 49(7):1092-111. PubMed ID: 18535010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AKR1C enzymes sustain therapy resistance in paediatric T-ALL.
    Bortolozzi R; Bresolin S; Rampazzo E; Paganin M; Maule F; Mariotto E; Boso D; Minuzzo S; Agnusdei V; Viola G; Te Kronnie G; Cazzaniga G; Basso G; Persano L
    Br J Cancer; 2018 Apr; 118(7):985-994. PubMed ID: 29515258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture.
    Tsumura H; Akimoto M; Kiyota H; Ishii Y; Ishikura H; Honma Y
    Leukemia; 2009 Apr; 23(4):753-60. PubMed ID: 19092848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cells.
    Kim JH; Lee SY; Oh SY; Han SI; Park HG; Yoo MA; Kang HS
    Oncol Rep; 2004 Dec; 12(6):1233-8. PubMed ID: 15547743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity.
    Shiiba M; Yamagami H; Yamamoto A; Minakawa Y; Okamoto A; Kasamatsu A; Sakamoto Y; Uzawa K; Takiguchi Y; Tanzawa H
    Oncol Rep; 2017 Apr; 37(4):2025-2032. PubMed ID: 28259989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of aldo-keto reductases AKR1C1-AKR1C4.
    Brožič P; Turk S; Rižner TL; Gobec S
    Curr Med Chem; 2011; 18(17):2554-65. PubMed ID: 21568892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methyl jasmonate induces cell cycle block and cell death in the amitochondriate parasite Trichomonas vaginalis.
    Ofer K; Gold D; Flescher E
    Int J Parasitol; 2008 Jul; 38(8-9):959-68. PubMed ID: 18294640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of reactive oxygen species and proline cycle in anthraquinone accumulation in Rubia tinctorum cell suspension cultures subjected to methyl jasmonate elicitation.
    Perassolo M; Quevedo CV; Busto VD; Giulietti AM; Talou JR
    Plant Physiol Biochem; 2011 Jul; 49(7):758-63. PubMed ID: 21511484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,3-Diarylpropenoic acids as selective non-steroidal inhibitors of type-5 17β-hydroxysteroid dehydrogenase (AKR1C3).
    Gazvoda M; Beranič N; Turk S; Burja B; Kočevar M; Rižner TL; Gobec S; Polanc S
    Eur J Med Chem; 2013 Apr; 62():89-97. PubMed ID: 23353746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1).
    El-Kabbani O; Dhagat U; Hara A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):105-11. PubMed ID: 21050889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New jasmonate analogues as potential anti-inflammatory agents.
    Dang HT; Lee HJ; Yoo ES; Hong J; Bao B; Choi JS; Jung JH
    Bioorg Med Chem; 2008 Dec; 16(24):10228-35. PubMed ID: 18996699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.
    Endo S; Matsunaga T; Kanamori A; Otsuji Y; Nagai H; Sundaram K; El-Kabbani O; Toyooka N; Ohta S; Hara A
    J Nat Prod; 2012 Apr; 75(4):716-21. PubMed ID: 22506594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones.
    Ishii Y; Kiyota H; Sakai S; Honma Y
    Leukemia; 2004 Aug; 18(8):1413-9. PubMed ID: 15229618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells.
    Chien CW; Ho IC; Lee TC
    Carcinogenesis; 2009 Oct; 30(10):1813-20. PubMed ID: 19696165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells.
    Fingrut O; Flescher E
    Leukemia; 2002 Apr; 16(4):608-16. PubMed ID: 11960340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioequivalence studies of tibolone in premenopausal women and effects on expression of the tibolone-metabolizing enzyme AKR1C (aldo-keto reductase) family caused by estradiol.
    Kang KW; Kim YG
    J Clin Pharmacol; 2008 Dec; 48(12):1430-7. PubMed ID: 18832293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs.
    Desmond JC; Mountford JC; Drayson MT; Walker EA; Hewison M; Ride JP; Luong QT; Hayden RE; Vanin EF; Bunce CM
    Cancer Res; 2003 Jan; 63(2):505-12. PubMed ID: 12543809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.